Characteristics | FAR-L(FAR < 0.079) (n=436) | FAR-H(FAR ≥ 0.079) (n=595) | p Value |
---|---|---|---|
Female, n (%) | 168 (38.5) | 225 (37.8) | 0.815 |
Age (years) | 69 (59, 78) | 72 (64, 80) | 0.097 |
BMI (kg/m2) | 24.5 (21.6, 27.2) | 24.0 (21.5, 27.0) |  < 0.001 |
Heart rate (bpm) | 80 (67, 98) | 81 (70, 96) | 0.126 |
SBP (mmHg) | 127 (114, 142) | 130 (115, 146) | 0.092 |
DBP (mmHg) | 75 (66,88) | 75 (65,86) | 0.141 |
Medical history, n (%) | |||
 Ischemic cardiomyopathy | 137 (38.5) | 252 (42.5) |  < 0.001 |
 None-ischemic cardiomyopathy | 117 (26.8) | 92 (15.5) |  < 0.001 |
 Valvular heart disease | 90 (20.6) | 113 (19.0) | 0.510 |
 Atrial fibrillation | 210 (48.2) | 236 (39.7) | 0.006 |
 Hypertension | 238 (54.6) | 387 (65.0) | 0.001 |
 Hyperlipidemia | 35 (8.0) | 53 (8.9) | 0.617 |
Glucose metabolism states | Â | Â | 0.001 |
 DM | 184 (42.4) | 321 (53.9) |  |
 Pre-DM | 146 (33.5) | 163 (27.4) |  |
 NGR | 106 (24.3) | 111 (18.7) |  |
Fibrinogen (g/L) | 2.4 (2.1, 2.7) | 3.5 (3.1, 4.1) |  < 0.001 |
ALB (g/L) | 39.6 (37.2, 41.7) | 37.0 (34.2, 39.3) |  < 0.001 |
FPG (mg/dL) | 5.00 (4.58, 5.97) | 5.2 (4.58, 6.58) | 0.010 |
HbA1c (%) | 6.0 (5.6, 6.7) | 6.2 (5.7, 7.1) | 0.008 |
Hemoglobin (g/L) | 133 (119, 145) | 125 (104, 138) |  < 0.001 |
BNP (pg/mL) | 422.0 (192.0, 990.8) | 569.0 (242.0, 1220.0) | 0.001 |
CRP (mg/L) | 3.6 (2.5, 5.2) | 7.0 (3.6, 24.7) |  < 0.001 |
Hematocrit (%) | 39.5 (35.8, 43.0) | 37.7 (31.8, 41.3) |  < 0.001 |
UA (μmol/L) | 423.0 (331.5, 535.8) | 437.0 (348.0, 548.0) | 0.345 |
Creatinine (μmol/L) | 79.0 (64.5, 100.1) | 87.9 (69.0, 123.0) |  < 0.001 |
Sodium (mmol/L) | 138.8 (136.0, 141.6) | 138.3 (135.0, 141.4) | 0.030 |
Potassium (mmol/L) | 3.9 (3.6, 4.2) | 3.9 (3.6, 4.2) | 0.725 |
WBC (× 109/L) | 5.9 (4.8,7.0) | 6.5 (5.2, 8.3) |  < 0.001 |
Total cholesterol (mmol/L) | 3.63 (3.00, 4.38) | 3.59 (2.94, 4.42) | 0.751 |
Triglyceride (mmol/L) | 1.00 (0.75, 1.52) | 1.01 (0.78, 1.37) | 0.455 |
HDL-C (mmol/L) | 1.00 (0.82, 1.23) | 0.98 (0.77, 1.14) | 0.002 |
LDL-C (mmol/L) | 2.00 (1.54, 2.62) | 2.01 (1.43, 2.74) | 0.760 |
AST (U/L) | 24.2 (18.3, 34.0) | 22.8 (16.7, 33.0) |  < 0.001 |
ALT (U/L) | 20.9 (14.7, 35.9) | 17.9 (11.8, 31.0) | 0.051 |
IVSTD (cm) | 0.9 (0.8, 1.0) | 0.9 (0.8, 1.1) | 0.055 |
LVPWTD (cm) | 0.9 (0.8, 1.0) | 0.9 (0.8, 1.0) | 0.092 |
LVDD (cm) | 6.0 (5.2, 6.8) | 5.8 (5.1, 6.5) | 0.004 |
LAD (cm) | 5.0 (4.4, 5.4) | 4.8 (4.4, 5.2) | 0.001 |
LVEF, n (%) | Â | Â | 0.064 |
 ≤ 40 | 244 (56.0) | 291 (48.9) | – |
41–49 | 61(14.0) | 106(17.8) | – |
 > 50 | 131(30.0) | 198(33.3) | – |
Medications at admission, n (%) | |||
 Antiplatelet agent | 182(40.1) | 273(45.9) | 0.186 |
 ACEI/ARB/ARNI | 175(40.1) | 231(38.8) | 0.670 |
 Beta-blocker | 336(77.1) | 471(79.2) | 0.420 |
 Statins | 241(55.3) | 320(53.8) | 0.634 |
 Diuretics | 388(89.0) | 526(88.4) | 0.769 |
 Digoxin | 50(11.5) | 72(12.1) | 0.756 |
 Aldosterone antagonist | 175(40.1) | 244(41) | 0.779 |
 Insulin | 62(14.2) | 72(12.1) | 0.371 |
 Metformin | 61(14.0) | 85(14.3) | 0.893 |
 Sulfonylureas | 3(0.7) | 6(1.0) | 0.585 |
 SGLT2i | 5(1.6) | 39(6.6) | 0.003 |